Connor, Clark & Lunn Investment Management (CC&L)’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-91,547	Closed	-$755K	–	1604
2023 Q2	$755K	Buy	91,547 +8,224	+10%	+$49.2K	﹤0.01%	878
2023 Q1	$466K	Sell	83,323 -987	-1%	-$5.65K	﹤0.01%	904
2022 Q4	$417K	Sell	84,310 -1,589	-2%	-$6.55K	﹤0.01%	913
2022 Q3	$412K	Buy	85,899 +1,972	+2%	+$8.46K	﹤0.01%	858
2022 Q2	$216K	Buy	83,927 +744	+0.9%	+$2.79K	﹤0.01%	917
2022 Q1	$479K	Buy	+83,183	New	+$747K	﹤0.01%	791

Other funds holding TRHC

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

BSCM

Berry Street Capital Management London, United Kingdom $340M AUM 65.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s TRHC Position: Q3 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2023, closing a stake of 91,547 shares — an estimated $755K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in TRHC in Q1 2022 and held it in 6 quarters. The position peaked at $755K in Q2 2023. 84 funds tracked by Wall St. Rank hold TRHC as of Q3 2023.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 91,547 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2023, an estimated $755K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2022 and held it in 6 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Tabula Rasa HealthCare, Inc. Common Stock position peaked at $755K in Q2 2023.
84 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2023, filed 13 Nov 2023.